Study Summary
This trial is testing if CBD is safe and affects the body in healthy people.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 2 Secondary · Reporting Duration: Time point -60,15, 30, 45 and 60 minutes and 1.5, 2, 3, 4, 6, 8, 10, 12 and 24 hours associated with administration of the CBD capsules
Trial Safety
Safety Progress
Side Effects for
Trial Design
4 Treatment Groups
Cannabidiol 400 mg with standard meal
1 of 4
Cannabidiol 200 mg with standard meal
1 of 4
Epidiolex 400 mg with standard meal
1 of 4
Cannabidiol 400 mg with high fat meal
1 of 4
Experimental Treatment
24 Total Participants · 4 Treatment Groups
Primary Treatment: Cannabidiol · No Placebo Group · Phase 1
Trial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 65 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| New York | 87.5% |
| California | 12.5% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Icahn School of Medicine at Mount Sinai | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Why did patients apply to this trial?
- "I'm interesting in advancing research efforts of cannabidiol and its family of compounds."
What questions have other patients asked about this trial?
- "Approximately when would this trial begin?"
How many prior treatments have patients received?
| 0 | 100.0% |
How responsive is this trial?
Typically responds via
| 50.0% | |
| Phone Call | 50.0% |
Average response time
- < 1 Day
Most responsive sites:
- Icahn School of Medicine at Mount Sinai: < 24 hours
Frequently Asked Questions
How many participants are currently engaged in this research initiative?
"Affirmative, the details listed on clinicaltrials.gov attest to this medical trial's continued recruitment of patients. It was initially announced on May 18th 2022 and has since been revised November 28th 2022. Currently 24 participants are sought from 1 location." - Anonymous Online Contributor
Is there an opportunity for me to partake in this experiment?
"This experiment requires 24 participants aged 18-65 with robust health. Criteria for inclusion include: comprehension of informed consent, English language fluency, healthy physical/psychological history and laboratory values, abstention from drugs or nicotine use, and sex as a biological variable (50% female recruitment)." - Anonymous Online Contributor
Are there any slots left in this clinical research for new participants?
"According to current information on clinicaltrials.gov, this research is recruiting participants as of now. The initial posting date was May 18th 2022 and the most recent update occurred November 28th 2022." - Anonymous Online Contributor
Has the FDA sanctioned Cannabidiol for therapeutic use?
"Considering that this is a Phase 1 clinical trial, with limited evidence regarding its safety and efficacy, Cannabidiol scored a 1 on our team's scale." - Anonymous Online Contributor
Does this research encompass individuals of advanced age?
"This study is designed for adults aged between 18 and 65. There are, however, 50 trials available to those younger than this set age range and 372 studies targeting senior citizens." - Anonymous Online Contributor